People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

challenging traditional understanding of heart disease risk factors. “While we recognize common contributors like high blood ...

New study from /Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the risk of several diseases.

Fact checked by Nick Blackmer A new study found a link between constipation and a higher risk of severe cardiovascular events ...

A recent study has shown that the weight-loss drug Ozempic, along with other medications in its class, may significantly ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...